Fiedler Susanne's most recent trade in Organon & Co. was a trade of 3,594 Common Stock done . Disclosure was reported to the exchange on Sept. 3, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 3,594 | 54,258 | - | 0 | Common Stock | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.35 per share. | 03 Sep 2024 | 1,145 | 53,113 | - | 20.4 | 23,301 | Common Stock |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2024 | 4,989 | 0 | - | - | Restricted Stock Units | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2024 | 4,989 | 52,253 | - | 0 | Common Stock | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.61 per share. | 04 May 2024 | 1,589 | 50,664 | - | 19.6 | 31,160 | Common Stock |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 7,794 | 49,747 | - | 0 | Common Stock | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 7,794 | 15,590 | - | - | Restricted Stock Units | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 4,771 | 43,473 | - | 0 | Common Stock | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2024 | 4,771 | 4,772 | - | - | Restricted Stock Units | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.80 per share. | 31 Mar 2024 | 2,483 | 47,264 | - | 18.8 | 46,680 | Common Stock |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.80 per share. | 31 Mar 2024 | 1,520 | 41,953 | - | 18.8 | 28,576 | Common Stock |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 119,825 | 119,825 | - | - | Stock Option (right to buy) | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 29,255 | 29,255 | - | - | Restricted Stock Units | |
| Organon Co | Fiedler Susanne | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 19,827 | 45,018 | - | - | Common Stock | |
| Organon Co | Fiedler Susanne | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2024 | 19,827 | 0 | - | - | Restricted Stock Units | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.04 per share. | 28 Feb 2024 | 6,316 | 38,702 | - | 18.0 | 113,941 | Common Stock |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2023 | 4,984 | 26,779 | - | - | Common Stock | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2023 | 4,984 | 4,989 | - | - | Restricted Stock Units | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.24 per share. | 04 May 2023 | 1,588 | 25,191 | - | 24.2 | 38,493 | Common Stock |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 2,168 | 22,814 | - | - | Common Stock | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 2,168 | 0 | - | - | Restricted Stock Units | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.63 per share. | 01 May 2023 | 1,019 | 21,795 | - | 24.6 | 25,098 | Common Stock |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 83,969 | 83,969 | - | - | Stock Option (right to buy) | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 23,384 | 23,384 | - | - | Restricted Stock Units | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 4,771 | 22,166 | - | 0 | Common Stock | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 4,771 | 9,543 | - | - | Restricted Stock Units | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.09 per share. | 31 Mar 2023 | 1,520 | 20,646 | - | 23.1 | 35,097 | Common Stock |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 9,116 | 21,681 | - | - | Common Stock | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 9,116 | 0 | - | - | Restricted Stock Units | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.09 per share. | 28 Feb 2023 | 4,286 | 17,395 | - | 25.1 | 107,536 | Common Stock |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 4,984 | 14,509 | - | - | Common Stock | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 4,984 | 4,984 | - | - | Restricted Stock Units | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.44 per share. | 03 May 2022 | 1,944 | 12,565 | - | 32.4 | 63,063 | Common Stock |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 1,579 | 10,268 | - | - | Common Stock | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2022 | 1,579 | 1,579 | - | - | Restricted Stock Units | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.08 per share. | 03 May 2022 | 743 | 9,525 | - | 32.1 | 23,835 | Common Stock |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2022 | 2,168 | 9,708 | - | - | Common Stock | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2022 | 2,168 | 2,168 | - | - | Restricted Stock Units | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.33 per share. | 01 May 2022 | 1,019 | 8,689 | - | 32.3 | 32,944 | Common Stock |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 44,091 | 44,091 | - | - | Stock Option (right to buy) | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 14,314 | 14,314 | - | - | Restricted Stock Units | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 8,718 | 0 | - | - | Restricted Stock Units | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2022 | 8,718 | 11,638 | - | - | Common Stock | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.57 per share. | 28 Feb 2022 | 4,098 | 7,540 | - | 37.6 | 153,962 | Common Stock |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2021 | 22,321 | 22,321 | - | - | Stock Option (Right to Buy) | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 115,980 | 115,980 | - | - | Stock Option (Right to Buy) | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 50,862 | 50,862 | - | - | Stock Option (Right to Buy) | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 46,215 | 46,215 | - | - | Stock Option (Right to Buy) | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 45,039 | 45,039 | - | - | Stock Option (Right to Buy) | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 35,646 | 35,646 | - | - | Stock Option (Right to Buy) | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 26,123 | 26,123 | - | - | Stock Option (Right to Buy) | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 19,828 | 19,828 | - | - | Restricted Stock Units | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 14,957 | 14,957 | - | - | Restricted Stock Units | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 9,116 | 9,116 | - | - | Restricted Stock Units | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 8,719 | 8,719 | - | - | Restricted Stock Units | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 4,336 | 4,336 | - | - | Restricted Stock Units | |
| Organon Co | Susanne Fiedler | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 1,579 | 1,579 | - | - | Restricted Stock Units |